logo
#

Latest news with #SBCMedicalGroupHoldingsIncorporated

SBC Medical任命Steven R. Cohen博士為醫療策略顧問以加快全球擴張
SBC Medical任命Steven R. Cohen博士為醫療策略顧問以加快全球擴張

Business Wire

time15-07-2025

  • Business
  • Business Wire

SBC Medical任命Steven R. Cohen博士為醫療策略顧問以加快全球擴張

加州爾灣--(BUSINESS WIRE)--(美國商業資訊)-- 為醫療企業及其診所提供綜合顧問與管理服務的全球供應商SBC Medical Group Holdings Incorporated (Nasdaq: SBC) ('SBC Medical')今日宣布,任命整形外科與顱顏外科領域的全球知名領軍人物Steven R. Cohen博士為醫療策略顧問。他的任命是公司擴大全球業務版圖、提升醫療卓越性策略中的重要一步。 Cohen博士是加州聖地牙哥先進美妝與重建外科中心Faces+的創辦人。他擁有超過30年的臨床經驗,以在再生美妝領域的開創性工作而廣為人知,包括脂肪源性幹細胞的臨床應用、面部骨骼美妝手術以及人工智慧在醫療創新中的整合。Cohen博士還是顱顏內牽引裝置和LipoCube的發明者,這兩項發明均已成為該領域的全球標準。 Cohen博士被《新聞週刊》評選為「美國最佳整形外科醫生」之一,撰寫了眾多科學出版品和教科書,是國際會議上廣受歡迎的演講嘉賓。他同時擔任加州大學聖地牙哥分校的臨床教授,也是包括美國整形外科醫師協會(ASPS)在內的多個全球學會的活躍成員。 自2024年9月在那斯達克上市以來,SBC Medical加快了其全球成長計畫。隨著Cohen博士的加盟,公司旨在提升醫療品質、強化在國際市場的品牌定位、擴大學術合作並完善醫師培訓計畫,從而進一步鞏固其身為真正全球化醫療集團的地位。 SBC Medical執行長Yoshiyuki Aikawa寄語 「非常榮幸能迎來到世界一流臨床醫師Steven R. Cohen博士加入我們的團隊。他深厚的專業知識和全球視野將在提升我們的醫療標準、醫師教育及品牌發展方面扮演變革性角色。我們期待他在公司進入新成長階段時所做出的貢獻。」 Steven R. Cohen博士寄語 「我很榮幸能加入SBC Medical,這家公司不僅發展迅速,還致力於創新和以病患為中心的醫療服務。SBC Medical在醫師教育和國際合作方面的投入與我自身的價值觀高度契合。我期待能為在全球推動更安全、有科學依據且精緻的再生美妝領域發展貢獻力量。」 關於Steven R. Cohen博士(部分簡介) 整形外科與顱顏外科委員會認證醫師 加州聖地牙哥Faces+創辦人兼醫療總監 加州大學聖地牙哥分校整形外科臨床教授 顱顏內牽引裝置與LipoCube的發明者 被《新聞週刊》評選為美國最佳整形外科醫生之一 面部重建、幹細胞治療及3D手術類比領域的全球權威 常受邀在國際學術學會發表主題演講;著有多部著作及同儕審查文章 如欲瞭解更多關於Steven R. Cohen博士的資訊,請造訪: 關於SBC Medical SBC Medical總部位於加州爾灣和日本東京,擁有並為美妝治療中心提供管理服務和產品。公司主要專注於為加盟診所提供全面的管理服務,包括但不限於跨各種平台(如社群媒體網路)的廣告和行銷需求、員工管理(如招募和培訓)、加盟診所客戶預訂、協助加盟診所員工進行房屋和設施租賃、加盟診所的建設和設計、醫療器材和醫療消耗品採購(轉售)、向加盟診所提供化妝品以向診所客戶轉售、正在申請專利和非專利醫療技術的使用授權、商標和品牌使用、IT軟體解決方案(包括但不限於遠端醫療顧問)、管理加盟診所的客戶獎勵計畫(客戶忠誠度積分計畫),以及針對加盟診所的支付工具。 如欲瞭解更多資訊,請造訪 免責聲明:本公告之原文版本乃官方授權版本。譯文僅供方便瞭解之用,煩請參照原文,原文版本乃唯一具法律效力之版本。

SBC Medical任命Steven R. Cohen博士为医疗战略顾问以加速全球扩张
SBC Medical任命Steven R. Cohen博士为医疗战略顾问以加速全球扩张

Business Wire

time15-07-2025

  • Business
  • Business Wire

SBC Medical任命Steven R. Cohen博士为医疗战略顾问以加速全球扩张

加州尔湾--(BUSINESS WIRE)--(美国商业资讯)-- 为医疗企业及其诊所提供综合咨询与管理服务的全球供应商SBC Medical Group Holdings Incorporated (Nasdaq: SBC) ('SBC Medical')今日宣布,任命整形外科与颅面外科领域的全球知名领军人物Steven R. Cohen博士为医疗战略顾问。他的任命是公司拓展全球业务版图、提升医疗卓越性战略中的重要一步。 Cohen博士是加州圣迭戈高级美容与重建外科中心Faces+的创始人。他拥有超过30年的临床经验,以在再生美容领域的开创性工作而广为人知,包括脂肪源性干细胞的临床应用、面部骨骼美容手术以及人工智能在医疗创新中的整合。Cohen博士还是颅面内牵引装置和LipoCube的发明者,这两项发明均已成为该领域的全球标准。 Cohen博士被《新闻周刊》评为'美国最佳整形外科医生'之一,撰写了众多科学出版物和教科书,是国际会议上备受追捧的演讲嘉宾。他同时担任加州大学圣迭戈分校的临床教授,也是包括美国整形外科医师协会(ASPS)在内的多个全球学会的活跃成员。 自2024年9月在纳斯达克上市以来,SBC Medical加速了其全球增长计划。随着Cohen博士的加盟,公司旨在提升医疗质量、强化在国际市场的品牌定位、扩大学术合作并完善医师培训项目,从而进一步巩固其作为真正全球化医疗集团的地位。 SBC Medical首席执行官Yoshiyuki Aikawa寄语 '非常荣幸能迎来到世界级临床医师Steven R. Cohen博士加入我们的团队。他深厚的专业知识和全球视野将在提升我们的医疗标准、医师教育及品牌发展方面发挥变革性作用。我们期待他在公司进入新增长阶段时所做出的贡献。' Steven R. Cohen博士寄语 '我很荣幸能加入SBC Medical,这家公司不仅发展迅速,还致力于创新和以患者为中心的医疗服务。SBC Medical在医师教育和国际合作方面的投入与我自身的价值观高度契合。我期待能为在全球范围内推动更安全、有科学依据且精致的再生美容领域发展贡献力量。' 关于Steven R. Cohen博士(部分简介) 整形外科与颅面外科委员会认证医师 加州圣迭戈Faces+创始人兼医疗总监 加州大学圣迭戈分校整形外科临床教授 颅面内牵引装置与LipoCube的发明者 被《新闻周刊》评为美国最佳整形外科医生之一 面部重建、干细胞治疗及3D手术模拟领域的全球权威 常受邀在国际学术学会发表主题演讲;著有多部著作及同行评议文章 如需了解更多关于Steven R. Cohen博士的信息,请访问: 关于SBC Medical SBC Medical总部位于加州尔湾和日本东京,拥有并为美容治疗中心提供管理服务和产品。公司主要专注于为加盟诊所提供全面的管理服务,包括但不限于跨各种平台(如社交媒体网络)的广告和营销需求、员工管理(如招聘和培训)、加盟诊所客户预约、协助加盟诊所员工进行房屋和设施租赁、加盟诊所的建设和设计、医疗器械和医疗消耗品采购(转售)、向加盟诊所提供化妆品以向诊所客户转售、正在申请专利和非专利医疗技术的使用许可、商标和品牌使用、IT软件解决方案(包括但不限于远程医疗咨询)、管理加盟诊所的客户奖励计划(客户忠诚度积分计划),以及面向加盟诊所的支付工具。 如需了解更多信息,请访问 免责声明:本公告之原文版本乃官方授权版本。译文仅供方便了解之用,烦请参照原文,原文版本乃唯一具法律效力之版本。

SBC Medical Announces Attendance at Upcoming Investor Events
SBC Medical Announces Attendance at Upcoming Investor Events

Yahoo

time28-05-2025

  • Business
  • Yahoo

SBC Medical Announces Attendance at Upcoming Investor Events

IRVINE, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) ('SBC Medical' or the 'Company'), a global franchise and provider of services for aesthetic clinics, today announced its upcoming investor event attendance. SBC Medical managements will be participating in a webcast company presentation and will also attend 1-x-1 investor meetings at these upcoming events: 1. Lytham Partners Spring 2025 Virtual Investor Conference Company WebcastThursday, May 29, 2025, at 2:00-2:30 PM(ET) The webcast can be accessed at Access: Same as above 1x1 MeetingsTo arrange a meeting at 2. Noble Capital Markets' Emerging Growth Virtual Equity Conference Company WebcastThursday, June 5, 2025 The webcast can be accessed at Access: 1x1 MeetingsTo arrange a meeting at 3. Sidoti Small-Cap Virtual Conference Company Webcast Wednesday, June 11, 2025, at 8:30-9:00 AM(ET) The webcast and post-event access will be provided when available. 1x1 MeetingsTo arrange a meeting at 4. Zacks SCR Life Sciences Virtual Investor Forum Company WebcastThursday, June 12, 2025, at 10:30-11:00AM(ET) The webcast and post-event access will be provided when available. About SBC Medical SBC Medical, headquartered in Irvine, California and Tokyo, Japan, owns and provides management services and products to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchisee clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensure of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic's customer rewards program (customer loyalty point program), and payment tools for the franchisee clinics. For more information, visithttps:// SBC Medical Group Holdings IncorporatedHikaru Fukui / Head of Investor Relationse-mail:ir@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Can SBC Medical Group Holdings Incorporated's (NASDAQ:SBC) ROE Continue To Surpass The Industry Average?
Can SBC Medical Group Holdings Incorporated's (NASDAQ:SBC) ROE Continue To Surpass The Industry Average?

Yahoo

time18-03-2025

  • Business
  • Yahoo

Can SBC Medical Group Holdings Incorporated's (NASDAQ:SBC) ROE Continue To Surpass The Industry Average?

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and why it is important. We'll use ROE to examine SBC Medical Group Holdings Incorporated (NASDAQ:SBC), by way of a worked example. ROE or return on equity is a useful tool to assess how effectively a company can generate returns on the investment it received from its shareholders. Simply put, it is used to assess the profitability of a company in relation to its equity capital. See our latest analysis for SBC Medical Group Holdings The formula for return on equity is: Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity So, based on the above formula, the ROE for SBC Medical Group Holdings is: 26% = US$54m ÷ US$206m (Based on the trailing twelve months to September 2024). The 'return' is the yearly profit. That means that for every $1 worth of shareholders' equity, the company generated $0.26 in profit. Arguably the easiest way to assess company's ROE is to compare it with the average in its industry. Importantly, this is far from a perfect measure, because companies differ significantly within the same industry classification. Pleasingly, SBC Medical Group Holdings has a superior ROE than the average (11%) in the Healthcare industry. That's what we like to see. However, bear in mind that a high ROE doesn't necessarily indicate efficient profit generation. Especially when a firm uses high levels of debt to finance its debt which may boost its ROE but the high leverage puts the company at risk. Companies usually need to invest money to grow their profits. That cash can come from issuing shares, retained earnings, or debt. In the first two cases, the ROE will capture this use of capital to grow. In the latter case, the debt used for growth will improve returns, but won't affect the total equity. Thus the use of debt can improve ROE, albeit along with extra risk in the case of stormy weather, metaphorically speaking. Although SBC Medical Group Holdings does use debt, its debt to equity ratio of 0.11 is still low. When I see a high ROE, fuelled by only modest debt, I suspect the business is high quality. Conservative use of debt to boost returns is usually a good move for shareholders, though it does leave the company more exposed to interest rate rises. Return on equity is a useful indicator of the ability of a business to generate profits and return them to shareholders. In our books, the highest quality companies have high return on equity, despite low debt. If two companies have around the same level of debt to equity, and one has a higher ROE, I'd generally prefer the one with higher ROE. But ROE is just one piece of a bigger puzzle, since high quality businesses often trade on high multiples of earnings. The rate at which profits are likely to grow, relative to the expectations of profit growth reflected in the current price, must be considered, too. So you might want to take a peek at this data-rich interactive graph of forecasts for the company. But note: SBC Medical Group Holdings may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store